Susan Newell
Women's Health · Mantachie, MSNPI 1376107409
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $328, 7.1 times the $47 reported in 2021.
Across 57 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$196
- Lilly USA, LLC$118
- AstraZeneca$106
- Sequel Med Tech, LLC$81
- Pfizer$63
- Corcept Therapeutics$59
- plus $334 from 13 others
What the payments were for
- Food & beverage$957100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $196 |
| Lilly USA, LLC | 7 | $118 |
| AstraZeneca | 6 | $106 |
| Sequel Med Tech, LLC | 4 | $81 |
| Pfizer | 4 | $63 |
| Corcept Therapeutics | 3 | $59 |
| Esperion Therapeutics, Inc. | 3 | $54 |
| AbbVie | 3 | $47 |
| Amgen | 3 | $47 |
| GSK | 1 | $25 |
| Dexcom, Inc. | 1 | $25 |
| Cequr Corporation | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Insulet Corporation | 1 | $16 |
| Bayer | 1 | $14 |
| BD | 1 | $13 |
How this compares
$957 in reported general payments places this provider in the 65th percentile of 66 women's health providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 19 | $28,906 |
| OzempicSemaglutide | 11 | $18,687 |
| Esomeprazole Magnesium | 14 | $528 |
| Omeprazole | 26 | $500 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $343 |
| Duloxetine Hcl | 11 | $342 |
| Ropinirole Hcl | 11 | $307 |
| Rosuvastatin Calcium | 16 | $255 |
| Gabapentin | 24 | $254 |
| Tizanidine Hcl | 17 | $196 |
| Metformin Hcl ErMetformin Hcl | 15 | $195 |
| Levothyroxine Sodium | 30 | $155 |
| Atorvastatin Calcium | 24 | $152 |
| Amlodipine Besylate | 30 | $148 |
| Buspirone Hcl | 17 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $118 | $28,90619 claims |
| Novo NordiskOzempic | $196 | $18,68711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 66 women's health providers in Mississippi.
Other women's health in Mantachie
- Casey HargettTupelo$7K
- Kathryn ElliottOxford$7K
- Jennifer FredricksonSouthaven$6K
- Wanda BrownOlive Branch$4K
- Deborah VerucchiSouthaven$3K
- Daphne HuttoPascagoula$3K
- Felecia BrownMeridian$3K
- Rachel FordJackson$3K
- Courtney MathisFlowood$2K
- Rebecca BatesFlowood$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.